Cargando…
Comparative Study on Chronic Obstructive Pulmonary Disease Screening Tools in Primary Healthcare Institutions in Beijing, China
BACKGROUND: Chronic obstructive pulmonary disease (COPD) has a high incidence rate in China, but the diagnosis rate remains insufficient. This study aimed to explore and compare COPD screening tools for primary healthcare institutions in China. PURPOSE: Exploring COPD Screening Tools and Their Combi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441650/ https://www.ncbi.nlm.nih.gov/pubmed/37608835 http://dx.doi.org/10.2147/COPD.S419550 |
_version_ | 1785093417327394816 |
---|---|
author | Yang, Xu Yao, Mi Yin, Delu Zhang, Na Li, Jing Jiang, Yan Fu, Rundong Qian, Yi |
author_facet | Yang, Xu Yao, Mi Yin, Delu Zhang, Na Li, Jing Jiang, Yan Fu, Rundong Qian, Yi |
author_sort | Yang, Xu |
collection | PubMed |
description | BACKGROUND: Chronic obstructive pulmonary disease (COPD) has a high incidence rate in China, but the diagnosis rate remains insufficient. This study aimed to explore and compare COPD screening tools for primary healthcare institutions in China. PURPOSE: Exploring COPD Screening Tools and Their Combined Use for Primary Healthcare Institutions in China. PATIENTS AND METHODS: From September 2022 to March 2023, a screening for COPD was conducted among residents aged 35 years and above in primary healthcare institutions in Beijing, China. The screening involved the use of the CAPTURE scale, COPD-SQ scale, and peak expiratory flow rate test. Any positive results from these screening tests were followed by further pulmonary function testing to confirm the diagnosis. Sensitivity, specificity, positive predictive value, negative predictive value, and receiver operating characteristic (ROC) curves were calculated for each screening tool alone and in combination. RESULTS: A total of 986 individuals completed the screening tests. The positive rates for the CAPTURE scale, COPD-SQ scale, and peak flow meter screening were 41.78%, 29.11%, and 52.03%, respectively. Of the participants, 166 (24.09%) underwent pulmonary function tests, with an average age of 61.69±13.68 years. The peak flow meter screening showed the highest sensitivity (83.78%) when used alone, while the COPD-SQ scale exhibited the best specificity (59.69%), positive predictive value (31.58%), and negative predictive value (58.56%). Significant differences (P<0.05) were observed between any two of the three screening tools. Among the combinations, the peak flow meter screening + COPD-SQ scale showed the highest accuracy, with a Youden index of 0.277 and an AUC of 0.638. CONCLUSION: There is variation in the accuracy of existing screening tools for COPD when used alone. For primary healthcare institutions, the optimal COPD screening tool is the combination of peak flow meter screening and the COPD-SQ questionnaire. If limited by screening equipment conditions, the COPD-SQ questionnaire can be used alone for screening. |
format | Online Article Text |
id | pubmed-10441650 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-104416502023-08-22 Comparative Study on Chronic Obstructive Pulmonary Disease Screening Tools in Primary Healthcare Institutions in Beijing, China Yang, Xu Yao, Mi Yin, Delu Zhang, Na Li, Jing Jiang, Yan Fu, Rundong Qian, Yi Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: Chronic obstructive pulmonary disease (COPD) has a high incidence rate in China, but the diagnosis rate remains insufficient. This study aimed to explore and compare COPD screening tools for primary healthcare institutions in China. PURPOSE: Exploring COPD Screening Tools and Their Combined Use for Primary Healthcare Institutions in China. PATIENTS AND METHODS: From September 2022 to March 2023, a screening for COPD was conducted among residents aged 35 years and above in primary healthcare institutions in Beijing, China. The screening involved the use of the CAPTURE scale, COPD-SQ scale, and peak expiratory flow rate test. Any positive results from these screening tests were followed by further pulmonary function testing to confirm the diagnosis. Sensitivity, specificity, positive predictive value, negative predictive value, and receiver operating characteristic (ROC) curves were calculated for each screening tool alone and in combination. RESULTS: A total of 986 individuals completed the screening tests. The positive rates for the CAPTURE scale, COPD-SQ scale, and peak flow meter screening were 41.78%, 29.11%, and 52.03%, respectively. Of the participants, 166 (24.09%) underwent pulmonary function tests, with an average age of 61.69±13.68 years. The peak flow meter screening showed the highest sensitivity (83.78%) when used alone, while the COPD-SQ scale exhibited the best specificity (59.69%), positive predictive value (31.58%), and negative predictive value (58.56%). Significant differences (P<0.05) were observed between any two of the three screening tools. Among the combinations, the peak flow meter screening + COPD-SQ scale showed the highest accuracy, with a Youden index of 0.277 and an AUC of 0.638. CONCLUSION: There is variation in the accuracy of existing screening tools for COPD when used alone. For primary healthcare institutions, the optimal COPD screening tool is the combination of peak flow meter screening and the COPD-SQ questionnaire. If limited by screening equipment conditions, the COPD-SQ questionnaire can be used alone for screening. Dove 2023-08-17 /pmc/articles/PMC10441650/ /pubmed/37608835 http://dx.doi.org/10.2147/COPD.S419550 Text en © 2023 Yang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Yang, Xu Yao, Mi Yin, Delu Zhang, Na Li, Jing Jiang, Yan Fu, Rundong Qian, Yi Comparative Study on Chronic Obstructive Pulmonary Disease Screening Tools in Primary Healthcare Institutions in Beijing, China |
title | Comparative Study on Chronic Obstructive Pulmonary Disease Screening Tools in Primary Healthcare Institutions in Beijing, China |
title_full | Comparative Study on Chronic Obstructive Pulmonary Disease Screening Tools in Primary Healthcare Institutions in Beijing, China |
title_fullStr | Comparative Study on Chronic Obstructive Pulmonary Disease Screening Tools in Primary Healthcare Institutions in Beijing, China |
title_full_unstemmed | Comparative Study on Chronic Obstructive Pulmonary Disease Screening Tools in Primary Healthcare Institutions in Beijing, China |
title_short | Comparative Study on Chronic Obstructive Pulmonary Disease Screening Tools in Primary Healthcare Institutions in Beijing, China |
title_sort | comparative study on chronic obstructive pulmonary disease screening tools in primary healthcare institutions in beijing, china |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441650/ https://www.ncbi.nlm.nih.gov/pubmed/37608835 http://dx.doi.org/10.2147/COPD.S419550 |
work_keys_str_mv | AT yangxu comparativestudyonchronicobstructivepulmonarydiseasescreeningtoolsinprimaryhealthcareinstitutionsinbeijingchina AT yaomi comparativestudyonchronicobstructivepulmonarydiseasescreeningtoolsinprimaryhealthcareinstitutionsinbeijingchina AT yindelu comparativestudyonchronicobstructivepulmonarydiseasescreeningtoolsinprimaryhealthcareinstitutionsinbeijingchina AT zhangna comparativestudyonchronicobstructivepulmonarydiseasescreeningtoolsinprimaryhealthcareinstitutionsinbeijingchina AT lijing comparativestudyonchronicobstructivepulmonarydiseasescreeningtoolsinprimaryhealthcareinstitutionsinbeijingchina AT jiangyan comparativestudyonchronicobstructivepulmonarydiseasescreeningtoolsinprimaryhealthcareinstitutionsinbeijingchina AT furundong comparativestudyonchronicobstructivepulmonarydiseasescreeningtoolsinprimaryhealthcareinstitutionsinbeijingchina AT qianyi comparativestudyonchronicobstructivepulmonarydiseasescreeningtoolsinprimaryhealthcareinstitutionsinbeijingchina |